Ocugen, Inc.

US$0.93As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OCGNHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (14.64%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.98
PE TTM —
TSR TTM (40.71%)
Mkt cap US$313.9M
ROIC (80.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.901
(2.59%)
(86.88%)
Hold 10|7|11|5|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
22.30%
27.57%
42.40%
44.50%
Revenue$M
20.85
21.24
21.51
22.56
4.22%
6.08%
6.11%
8.66%
Peers (US$313.9M)
Cap (US$)
PE
314.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.090
0.181
0.191
EBIT/Intx
0.104
0.314
0.239
Own earn%
52.20
2.89
7.97
Sh yield%
47.84
17.77
16.71
Owners
Insiders/Inst%
11.70
66.08
Short interest%
4.78
SBC / revenue%
4.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–18
$1 testx
0.0
Incr. ROIC%
3